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Abstract 
Chitosan, a deacetylated chitin, is known to have a broad spectrum of antimicrobial activity. The 
objectives of this research were to determine the in vitro time and temperature dependent effects 
of chitosan with different molecular weights (53, 421 and ~1150 kDa) at two concentrations (35 
percent and 0.7%) against the human noroviral surrogates, feline calicivirus (FCV-F9) and 
murine norovirus (MNV-1) at two temperatures (37oC and 18oC) over 2 hours. The virus titers 
were determined using standard plaque assays and compared to untreated virus controls. The 
tested chitosans were shown to decrease FCV-F9 titers, but had no observable effects on MNV-
1. Chitosan with molecular weight (M.W.) of 53 kDa at 0.35% decreased FCV-F9 titers by ~1.0 
log PFU/ml, whereas at 0.7% decreased FCV-F9 titers by ~3.0 log PFU/ml after 2 h at 37oC and 
by ~1.0 log PFU/ml after both 1 and 2 h at 18oC. Chitosan with M.W. of 421 kDa at 0.35% 
decreased FCV-F9 titers by ~1.0 log PFU/ml whereas at 0.7% decreased FCV-F9 titers by ~2.0 
at 37oC after 2 h. Chitosans with 421 and ~ 1150 kDa at 0.35% and 0.7% decreased FCV-F9 
titers by ~1.0 log PFU/ml after 2 h at 18oC.  Chitosan with ~ 1150 kDa at 0.35% decreased FCV-
F9 titers by ~1.0 log PFU/ml whereas at 0.7% decreased FCV-F9 titers by ~2.0 log PFU/ml at 
37oC after 2 h. The results show that, in general, higher temperature and longer incubation cause 
greater inactivation of FCV-F9, with 53 kDa chitosan showing the greatest activity.  
Transmission electron microscopy did not show clear evidence of capsid damage of FCV-F9 
treated chitosan and chitosan’s mode of action could not be clearly elucidated. Overall, the tested 
chitosans showed minimal effect against MNV-1. Thus, caution must be used in interpreting the 
data based solely on chitosan’s effects against FCV-F9 alone for the use of chitosan as a natural 
antiviral agent to control foodborne viral infections. 
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Chapter 1 – Literature Review 
Foodborne Viruses and Inactivation 
Diseases of bacterial, viral, or parasitic origin are frequently spread through foods. Each 
year, foodborne diseases have been known to cause around 9.4 million illnesses and 1,351 deaths 
in the United States (Scallan et al., 2011). Viruses are estimated to be the responsible for 59% of 
the total foodborne illnesses, 27% of the hospitalizations, and 12% of the deaths (Scallan et al., 
2011).  Enteric viruses in water and food are an important cause of mortality in infants and 
young children in less developed countries (Bernstein, 2009).  
Human enteric virus transmission is known to occur through contaminated food or water 
(by the fecal-oral route), person to person, aerosols, and contact with contaminated surfaces. 
Human enteric viruses have a low infectious dose and as few as 10 virus particles are capable of 
causing illness (CDC 2010a). Foods that are associated with transmission include shellfish, fresh 
produce and ready-to-eat (RTE) foods that do not undergo further processing (Sair et al., 2002a). 
Infected food handlers have been responsible for contaminating foods with viruses causing 
outbreaks of foodborne illness (Greig, et al., 2007).  Human enteric viruses are environmentally 
stable, resistant to pH and enzymes of the gastrointestinal tract (Jaykus et al., 2000).  Food serves 
as a vehicle for viral transmission because of the ability of the viruses to withstand many food 
processing and storage conditions (Sair et al., 2002b). The main viruses associated with 
foodborne and waterborne diseases include human noroviruses, hepatitis A virus, adenoviruses, 
Aichi virus (AiV), astroviruses, rotaviruses, sapoviruses, and other enteroviruses (CDC, 2010a; 
Hirneisen et al., 2010). 
Human noroviruses belong to the Caliciviridae family, and are non-enveloped, single 
stranded, positive-sense RNA viruses. Their RNA is about 7.5 kilobytes in length. They are 
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icosahedral in shape and 27-38 nanometers in size with the RNA enclosed in a capsid 
(Donaldson et al., 2008; Hyde et al., 2009; Taube et al., 2010). Noroviruses are broadly classified 
into five genogroups and human norovirus isolates belong to genogroups GI, GII, and GIV. 
Genotypes GIII infect cattle and genotypes GV have been isolated from mice. GII genotypes, 
distinct from human strains, infect swine. Members of the genogroup GII are the most common 
strains and over time evolve into new variants, causing pandemic outbreaks about every 2–4 
years such as the genogroup II.4b norovirus (Glass et al. 2009; Siebenga et al., 2009).  
Human noroviruses usually cause relatively mild gastroenteritis, with vomiting and 
diarrhea which lasts for 1–3 days. However, there are reports which show serious consequences 
of norovirus infection, with benign seizures in infants (Chen et al., 2009) and chronic debilitating 
diarrhea in immunocompromised patients (Roddie et al., 2009). Usually, the incubation period 
following exposure to norovirus is between 24 and 48 h. The feces of infected individuals may 
contain 106 or more virus particles per gram (Teunis et al., 2008).   Susceptibility to norovirus 
infection requires the involvement of acquired immunity and genetic resistance (Parrino et. al., 
1977).Host genotype is an important factor in the development of norovirus infection because it 
depends on the presence of specific human histo-blood group antigen (HBGA) receptors in the 
gut of susceptible hosts. An increased susceptibility of Norwalk virus infection was associated to 
blood group O (Lindesmith et. al., 2003).  
Human noroviruses cannot be cultured in the laboratories, which makes it difficult to 
assess the effectiveness of processing methods and interventions to prevent contamination 
(Duizer et al., 2004). Hence cultivable surrogates such as feline calicivirus (FCV-F9), murine 
norovirus (MNV-1), and coliphage MS2, are used to determine infectivity after treatments. 
Recently, Tulane virus has been also cultivated in the lab and is being investigated as an alternate 
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surrogate for human noroviruses (Herniesen and Kniel, 2013). A few properties of these 
surrogates are described below.  
Feline calcivirus (FCV-F9) also belongs to the same Caliciviridae family as human 
noroviruses and has been most commonly used as a surrogate for human noroviruses in the past 
(Bidawid et al., 2000; D’Souza et al., 2006). However, FCV-F9 is a respiratory virus that is more 
susceptible to environmental conditions, like low pH than human noroviruses and so the 
suitability of this virus as a human norovirus surrogate remains questionable (Duizer et al., 2004; 
Perry et al., 2009; Radford et al., 2007; Cannon et al., 2006).  
Murine norovirus (MNV-1) is a recently cultivable virus and is more resistant to 
environmental conditions than FCV-F9. Murine norovirus belongs to the genogroup V within the 
Norovirus genus and is shed in feces, and hence considered a more suitable surrogate for use 
under some conditions (such as low pH) (Bae and Schwab, 2008; Cannon et al., 2006; Su et al., 
2009; Wobus et al., 2006). 
Bacteriophage MS2 is a member of the Leviviridae family and like human noroviruses 
is a positive sense, single stranded RNA virus, about 22 - 29 nm in size with an icosahedral 
shape (Dawson et al., 2005; Langlet et al., 2007; Toropova et al., 2008). MS2 is used as a 
surrogate for RNA viruses for environmental studies of water and soil, since it is resistant to 
environmental conditions (Dawson et al., 2005; Guan et al., 2006; Shin and Sobsey, 2003).  
Tulane Virus (TV) was recently isolated from the stool samples of captive juvenile 
rhesus macaques (Macaca mulatta) at the Tulane National Primate Research Center. TV has a 
typical calcivirus morphology, 36 nm in diameter, and represents a new calicivirus proposed 
genus “Recovirus” (rhesus enteric CV) (Farkas, et al., 2008). TV contains a complete genome of 
6,714 nucleotides plus a poly (A) tail and similar to human noroviruses has three open reading 
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frames (ORFs) that encode the nonstructural (NS) polyprotein (ORF1), the capsid protein 
(ORF2), with a molecular mass of 57.9 kDa, as well as a minor structural protein (ORF3), with 
an isoelectric point (pI) of 10.0 (Farkas, et al., 2008). These researchers could culture TV in a 
monkey kidney cell line (LLC-MK2) with typical cytopathic effects.  
Sapoviruses of the family of Caliciviridae, also contain RNA viruses of 7.5 kb in length. 
They were detected at high concentrations in stool samples of asymptomatic food handlers 
associated with an outbreak in Japan (Yoshida at al. 2009) along with other enteric viruses and 
associated with clams (Nakagawa-Okamoto et al., 2009). In 2007, Sapovirus caused a 
gastroenteritis outbreak affecting 55 college students in Taiwain (Wu et al., 2008). It was 
believed to be a foodborne illness though no vehicle of transmission of Sapovirus was identified 
(Wu et al., 2008).  
Hepatitis A virus (HAV) is non-enveloped with single-strand positive sense RNA 
genome about ~7.5 kb in size and belongs to the Picornaviridae family. The symptoms are 
severe that lasts for 4 to 6 weeks including fever, abdominal discomfort followed by jaundice. 
HAV infection occurs by fecal–oral route and the virus is excreted in feces. Often, HAV 
outbreaks are a result of waterborne transmission although it has been traced to foods 
contaminated by food handlers as well as to foods contaminated before distribution. HAV 
incubation period averages 28 days (4 to 6 weeks) making it difficult to trace the origin/source in 
many outbreaks. HAV is relatively heat stable, survives more than a month in the environment 
and over a year in the frozen state (Greening, 2006a). 
Thousands of HAV infection incidents are reported annually (2,585 cases in 2008), 
though the national incidence of HAV has dramatically decreased to 92%, since the introduction 
of HAV vaccines in 1995(CDC, 2010b). Hepatitis A vaccination is recommended for people at 
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increased risk for infection or complications from Hepatitis A infection, and for all children at 1 
year of age (CDC, 2009). The HAV vaccines consist of two-dose series, with a booster dose 
administered 6-12 months after the primary immunization (CDC, 2009). In underdeveloped 
countries, most children are exposed to the HAV virus by age six and have a mild illness or are 
asymptomatic which induces life-long immunity. With better drinking water and sewage 
systems, children in more developed countries are not typically exposed to HAV, therefore a 
high percentage of the population lacks immunity. When people from developed countries travel 
to underdeveloped countries or consume foods harvested in underdeveloped countries, people 
may be exposed to HAV and become ill (Payne and Coulombier, 2009). 
Adenoviruses belong to the family of Adenoviridae, and are icosahedral, non-enveloped 
viruses with a double-stranded DNA genome. Adenoviruses are often associated with respiratory 
infections. Adenoviruses have been detected in shellfish, wastewater, and surface waters in many 
locations. Certain serotypes, 40 and 41, cause gastroenteritis and have been suspected in 
foodborne infections (Greening, 2006a). 
Aichi virus is a non-enveloped single-strand RNA virus of the genus Kobuvirus in the 
Picornaviridae family. The genome of Aichi virus contains 8,280 nucleotides and a poly (A) tail. 
Aichi virus was recently recognized as a cause of oyster-associated gastroenteritis (Yamashita, 
1993). Aichi virus been detected in shellfish and diarrheic stool samples from China, Japan, 
France, Germany and other countries (Le Guyader, 2008; Vilarino 2009; Yang, 2009). There are 
other vehicles of foodborne infection suspected besides shellfish, but they have not yet been 
identified. 
Astroviruses are non-enveloped positive-sense single-stranded RNA viruses with a 
genome size of 6.8 to 7.9 kb. Astroviruses cause enteric disease especially in children, elderly, 
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and immunocompromised persons. At 14 schools in Japan, a large outbreak of diarrhea affecting 
>4700 people was caused by astrovirus and food provided by a common supplier to the schools 
was believed to be the means of infection transmission (Oishi, 1994). Astroviruses also are 
known to cause an important disease in turkeys but there is no evidence that astrovirus is 
zoonotic (Koci and Schultz-Cherry, 2002). 
Rotaviruses belong to the family Reoviridae. Rotaviruses contain double-stranded RNA 
(dsRNA) (Estes and Cohen, 1989), are non-enveloped icosahedral-shaped viruses approximately 
75 nm in diameter. Rotaviruses are responsible for a large percentage of cases of diarrhea in 
children under 5 years of age. In the United States (U.S.) rotaviruses have been the most 
common cause agent for hospitalization for diarrhea among children. The recently developed 
rotavirus vaccine for children is expected to decrease morbidity (Bernstein, 2009). In Germany, 
rotavirus was detected in potato stew served during an outbreak in a sanatorium (Mayr et al., 
2009). At a college, in the United States, sandwiches probably contaminated by a cafeteria 
worker were associated with an outbreak in 2000 (Fletcher at al., 2000).  
Parvoviruses are very small, non-enveloped single-DNA viruses of average genome size 
of 5000 nucleotides long, belong to Parvoviridae family, of about 18–26 nm in diameter. 
Parvoviruses have been associated with human respiratory and foodborne illness traced to 
contaminated shellfish (Greening, 2006a).  
Bocavirus, was first isolated in 2005, is associated with respiratory disease that has also 
been detected in the digestive tract. Bocavirus spread by the fecal–oral and respiratory routes. 
Bocavirus are very resistant to heat and many disinfectants (Chow and Esper , 2009; Eterpi, 
2009). 
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Poliovirus belongs to the genus of enteroviruses of the family Picornaviridae.  Polio 
virus has a single-stranded positive-sense RNA genome of about 7.5 kb nucleotides and the virus 
is 30 nm in diameter with an icosahedral symmetry. The most frequently reported vehicles 
implicated in foodborne outbreaks include raw milk, lemonade and cream-filled pastries (Cliver, 
2008). Research has found that poliovirus has the ability to survive in the middle of hamburgers 
cooked to 60ºC (rare) (Sullivan, 1975) and in dry as well as semi-dry fermented sausages 
(Kantor and Potter, 1975). During 1960s to 1970s in the U.S, poliovirus was detected in market 
samples of raw meat (Cliver, 1986). With mass immunization campaigns, few human cases of 
polio now occur except in a few countries where routine polio vaccination of children has not 
been achieved. Even though polio was eradicated from the United States in 1979, polio is still 
documented in many developing countries and global eradication initiative programs are in place 
(de Quadros et al., 1992). 
Control Strategies for foodborne viruses. 
Interventions for controlling microorganisms in foods include low pH, drying, decreased water 
activity, thermal inactivation, irradiation, high pressure, ultraviolet light, Pulsed electric fields, 
and chemical disinfection including chlorine, chlorine dioxide and ozone. 
Low pH  
Many enteric viruses can tolerate pH values of 3 or 4 and as high as 9 or 10 (FAO/WHO, 2008). 
At pH 1, HAV was reported to remain infectious after 90 min and at pH 2.7, norovirus in a stool 
filtrate remained infectious after 3 h (Baert et al., 2009). Foodborne viruses must survive passage 
through the acidic stomach. At pH 4.5–5.5, little to no reduction in norovirus titers were reported 
after storage in foods like ketchup and salads (Mormann at al., 2010).  Hence, low pH does not 
help to curb the spread of norovirus illness through food. 
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Drying/Decreased Water Activity  
To limit bacterial growth, sodium chloride as well as drying (where reduction of water activity is 
obtained by drying or addition of water-soluble substances like sugar or salt) have been used for 
thousands of years to decrease water activity in food products like meat, fish, vegetables, eggs, 
and some fruits. Most often drying increases viral resistance to stresses like heat and sanitizers 
(Terpstra et al., 2007; Welch et al., 2006). Salt has shown a protective effect on hepatitis A virus 
subjected to high pressure in media. HAV titer was reduced by 0.4 log in the presence of 6% 
NaCl for 1 min at 400 MPa at 50ºC. In the absence of added salt, HAV titer was reduced by 3.9 
logs (Kingsley and Chen, 2009; Kingsley and Chen, 2008). 
Thermal Inactivation  
The high temperature used for food preservation is based on the destructive effects of heat on 
microorganisms. There are two categories commonly used for high-temperature: pasteurization 
and sterilization. Pasteurization uses high temperature for the destruction of disease-causing 
microorganisms or for the reduction in the number of spoilage microorganisms. Sterilization uses 
high temperature to destroy all viable organisms (Ramesh, 1999). Norovirus-like virus particles 
(VLPs) are highly stable up to 55ºC, at temperatures above 60oC, norovirus VLPs undergo phase 
transitions and the secondary, tertiary, and quaternary protein level structures are disrupted 
(Ausar et al., 2006). Poliovirus has the ability to persist in oysters after 30 min of steaming at an 
internal temperature of 94 ºC (DiGirolamo et al., 1970). Noroviruses are known to be more heat-
resistant than poliovirus showing their ability to survive the steaming process (Dolin et al., 
1972). Complete HAV inactivation in shellfish meat was achieved after steaming to an internal 
temperature of 85 to 90 ºC for 1.5 min (Millard et al., 1987). Excessive shellfish heating causes 
undesirable organoleptic changes like toughening of the meat texture (West et al., 1985). Even 
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though heating offers some inactivation of foodborne viruses, most of the foods implicated in 
viral outbreaks are not heat-treated before consumption. Therefore, novel nonthermal 
technologies such as irradiation, Ultraviolet (UV) Light, high-pressure, and PEFs are being 
studied as alternative means for viral inactivation in foods. 
Irradiation  
Irradiation may be useful in controlling bacteria, parasites, and insects in foods. High irradiation 
doses are required for significant reduction of viral titers which may adversely affect sensory 
properties of foods. Due to their small size viruses are more resistant to irradiation than bacteria, 
including spore-formers.  Hepatitis A virus, poliovirus, and rotavirus in oysters were reported to 
have D10 values of 2.94, 2.0 and 2.4 kilogray (kGy), respectively (Baert et al., 2009; Jung et al., 
2009). A dose of 3 kGy was needed for 1-log reduction of hepatitis A virus on lettuce or 
strawberries (Bidawid et al., 2000). 
High hydrostatic pressure (HHP)/ High pressure homogenization (HPH)  
High hydrostatic pressure (HHP) can be applied to foods to inactivate foodborne microorganisms 
and prolong the shelf life of food products (Kovac et al., 2010; Guerrero-Beltran et al., 2005; 
Korhonen et al., 1998). HHP yields higher quality products with unaffected sensory and 
nutritional attributes (San Martin et al., 2002). Pressure is transmitted uniformly through the 
pressure-transferring medium and pressure effects are independent of product size and geometry. 
(Guerrero-Beltran et al., 2005; Knorr, 1993). Generally, vegetative bacteria are the most 
sensitive to HHP, followed by yeasts and molds, whereas viruses and bacterial spores are 
reportedly more resistant (Kovac et al., 2010; Patterson et al., 2007). Inactivation of 
microorganisms is found to be time-dependent and also dependent on the initial number (titer) of 
microbes. High pressure homogenization (HPH) is another promising novel non-thermal 
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processing method for fluid foods. HPH is used extensively in the food industry, for creating 
dairy and food emulsions, to improve texture, flavor, and shelf-life attributes (Diels and Michiels 
2006; Dickinson and Stainby, 1988). Gram-negative bacteria are more sensitive to HPH than 
Gram-positive bacteria, because of the thinner peptidoglycan layer (Kelemen and Sharpe, 1979; 
Wuytack et al., 2002). HPH has been used to inactivate norovirus surrogates. At pressures of 250 
MPa or more, bacteriophage MS2 showed 3.3 log PFU/ml reduction and MNV-1 showed 
reduction of 0.8 log PFU/ml at 300 MPa (D’Souza et al., 2009).  
Ultraviolet (UV) Light  
Short wave ultraviolet light (has a wavelength of 180 to 280 nm) primarily damages the RNA 
and DNA genome of viruses and at very high doses can damage proteins as well. Thymine or 
uracil dimers are formed in the nucleic acids, which results in mutations. Because only one 
strand is damaged and the other strand can serve as a template for repair, double-stranded DNA 
and RNA viruses are more resistant to UV light (Eischeidj et al., 2009; Hirneisen et al., 2010). 
UV light leaves no residues but has limited applications in the food industry because UV light 
has low penetration power. Also turbidity in liquids decreases the effectiveness of UV light. UV 
light is used for disinfection of water as well as for inactivating microbes on environmental and 
food surfaces. For FCV, HAV, PV1, MS2 and phiX174, the decimal inactivation doses (the dose 
that is required to inactivate 90 percent of the initial population) of UV were 47.85, 36.50, 24.10, 
23.04 and 15.48 mW s/cm2, respectively. The most UV resistant among the tested viruses was 
FCV (Nuanualsuwan et al., 2002). Inactivation of HAV, FCV, and Aichi virus by UV on lettuce 
was in the range of 4.5–4.6 logs whereas on strawberries, the range was only 1.9–2.6 logs and  
the uneven matrix of the strawberry surface protected some virus particles from the UV light 
(Fino and Kniel, 2008 ).  
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Pulsed electric fields (PEF)  
For microbial inactivation, PEF uses short bursts of electricity while causing minimal effect on 
food quality. PEF is used to treat liquid and semiliquid food products including juices, milk, 
yogurt, soups, and liquid eggs (Ramaswamy et al., 2005). Electric field, wave forms and 
strengths, distribution of the treatment chamber, temperature, pressure, and time of exposure are 
the processing variables (Clark, 2006). PEF inactivates bacteria and fungi in field strengths of 
35000 V/cm (Clark, 2006). When bacteria are exposed to high electrical field pulses, pores 
develop in the cell membrane that increases membrane permeability allowing the loss of cellular 
contents (Clark, 2006). PEF has shown little effect on spores (Clark, 2006). Limited research has 
been conducted on the effect of PEF on enteric virus inactivation. Rotavirus was resistant to PEF 
treatment of 20 to 29 kV/cm for 145.6 μs. This ineffectiveness may be due to the protein capsid 
on enteric viruses compared to the lipid membranes of bacterial cells (Khadre and Yousef, 2002). 
Chlorine  
In Hamburg, Germany, in 1893, chlorine was first used as a disinfectant in a wastewater 
treatment plant (Vaughn and Novotny, 1991). Chlorine is the most commonly used sanitizing 
agent, chlorine gas (Cl2), calcium hypochlorite (CaClO2), and sodium hypochlorite (NaOCl2) 
are the three forms of chlorine approved for use (Fonseca, 2006). The efficacy of chlorine 
disinfection relies on the pH of the chlorine solution. When pH values are greater than 8.0, 
chlorine will be ionized to form the hypochlorite ion and at pH levels below 6.0, the available 
chlorine is in the form of hypochlorous acid (HOCl) (95%), a more potent disinfectant (Clark et 
al., 1956; Weidenkopf, 1958).  A 10-fold increase in poliovirus inactivation with the HOCl form 
of chlorine has been reported (Weidenkopf, 1958). Disinfection by chlorine has also been shown 
to be affected by a variation in temperature. Poliovirus inactivation rates were increased 2-fold 
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when the temperature was increased from 5 to 25 °C (Scarpino, 1972). In the United States, 
chlorine is predominantly used for the disinfection of water (Vaughn and Novotny, 1991). 
Chlorine is used in the processing of fresh produce, either as a spray to reduce soil and 
microbiota associated with lettuce or as a flume water additive to control cross-contamination for 
tomatoes, carrots, melons, citrus, bulb vegetables, leafy greens, and potatoes. In a spray, chlorine 
is commonly used at 50 to 200 mg/L for 2 to 10 s at a temperature range of 12 to 21°C between 
pH 5 and 7. In flume water, depending on the food product, chlorine is used from 10 to 200 mg/L 
for 30 s to 5 min at 12 to 21°C between pH 5 and 7 (Burnett, 2008). There was 95%, 98%, and 
99% inactivation of poliovirus type 1, phiX174 phage and MS2 phage, respectively, on 
strawberries after a 2-min water wash with 50 mg/L chlorine at 43°C (Lukasik et al., 2003). FCV 
was inactivated by approximately 1 log on both strawberries and lettuce after 10 min with 80 
mg/L chlorine (Gulati et al., 2001). HAV and MS2 were inactivated by 90% to 99% when 20 
mg/L of free chlorine was applied for 5 to 10 min on strawberries, cherry tomatoes, and lettuce 
leaf pieces (Casteel et al., 2008). Chlorine effectiveness is highly dependent on the organic load, 
therefore, monitoring and controlling the chlorine level is critical. The formation of chlorine 
byproducts and the potential for toxic chlorine gas formation are the disadvantages of chlorine. 
Chlorine also has the ability to form chlorinated byproducts that may be detrimental to the 
environment and can corrode processing equipment (Burnett, 2008).  
Chlorine dioxide (ClO2) 
ClO2 is an oxidizing agent extremely soluble in water and up to 5 times more soluble than 
chlorine. Unlike chlorine, ClO2 does not form trihalomethanes by reacting with ammonia or 
organic compounds (White, 1978; Schnoor et al., 1979). The oxidation of iron and manganese 
reducing discoloration of finished water, inability to react with ammonia, and relative pH 
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stability are advantages of ClO2 disinfection (Aieta and Berg, 1986). The disadvantages are that 
ClO2 must be generated on site due to its instability and it has the potential to be explosive when 
concentrated (Beuchat, 1998). ClO2 was found to be twice as effective as chlorine in the 
inactivation of poliovirus type 1 and bacteriophage in wastewater (Tifft et al., 1977). In the 
presence of high amounts of organic matter, such as those found in flume processing waters and 
dump tanks, activity of ClO2 was not found to be substantially reduced (Bernard et al.,1965). 
ClO2 inactivated poliovirus more efficiently at pH 10.0 when compared to pH 6.0 and this 
observed pH effect which could be that the high pH increases the sensitivity of the virus to ClO2 
attack. It is also possible that the form of ClO2 in alkaline solution (Chlorate anion - ClO−3) is 
the most active species for viral inactivation (Alvarez and O’Brien, 1982). ClO2 usage with 
wastewater effluents that are generally more acidic could compromise the greater efficacy of 
ClO2 at alkaline pH (Vaughn and Novotny, 1991). ClO2 could be used as a spray to remove soil 
to reduce microbiota associated with lettuce surfaces and its residual concentration is usually 3 
mg/L, applied from 30 s to 5 min at a temperature range of 2 to 24 ◦C at a pH range of 6 to 10 
(Burnett, 2008). A maximum of 200 mg/L ClO2 is allowed for equipment sanitation, in fruit and 
vegetable processing in the United States. 
Ozone  
Ozone gas is a strong oxidizing agent which can effectively kill microorganisms. Non-enveloped 
viruses, with their protein coats exposed to ozone, undergo protein peroxidation while lipid 
oxides are formed in enveloped viruses (Murray et al., 2008). Ozone gas is used for surface 
disinfection (Hudson et al., 2009) and the gas may be bubbled through liquids such as water and 
juices. Ozonated water has been used to rinse produce and chicken carcasses. Organic 
compounds present in foods react with ozone, causing a decrease in the amount of available gas 
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to inactivate microbes. Besides flavors, colors of the food alter when ozone reacts with food 
components. Ozone reacts more rapidly with organic material as temperature increases, but 
ozone also decomposes more quickly. At pH 5, ozone is most stable in solution and starts to 
decompose as pH increases (Hirneisen et al., 2010). Under more acidic conditions, some viruses, 
including poliovirus, are more resistant to ozone (Roy et al., 1982). At 20°C, 0.25 to 0.38 mg of 
ozone per liter was required for complete inactivation of hepatitis A virus (Herbold, 1989). For 
norovirus, a dose of 0.37 mg of ozone/liter could reduce the virus by >3 log within a contact time 
of 10 seconds (Shin, and Sobsey, 2003). 
In addition to the chemicals and processes described above, natural antiviral agents such as 
chitosan are being researched to control foodborne viruses. 
Chitosan 
Chitosan is a linear cationic polysaccharide and a deacteylated derivative of chitin which is the 
major structural biopolymer in crustacean shells, fungi, and insects (Roller and Covill, 1999). 
Chitosan is present naturally in fungi, zygomycetes (Shahidi et al., 1999). Chitosan is not 
generally recognized as safe (GRAS) in the United States, although chitosan is approved as a 
food additive in Japan and Korea (No et al., 2007). Chitosan has been sold as a dietary 
supplement and as an additive to dog food (Park et al., 2002) and chitosan has been accepted as a 
bio pesticide (Docket No. EPA-HQOPP- 2007-0566-0019). Chitosan is used to form beads, 
films, fibers, and gels (Guibal 2004; Sankararamakrishnan et al., 2006; Zivanovic et al. 2008), as 
a chelator,  in waste water management (Shahidi et al., 1999), and as wound dressings in 
medicine (Koide, 1998).  The use of chitosan in the food industry has been explored in various 
fields, as clarifying agent in juice, as an antimicrobial, as an antioxidant, as a packaging material, 
and as a thickening agent in beverages (Devlieghere et al., 2004; Shahidi et al., 1999; Xie et al., 
2001).  
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Chitosan Antimicrobial Properties 
 
Chitosan’s antibacterial properties have been widely confirmed and investigated (Coma et al., 
2003; Dutta et al., 2009; Kong et al., 2008; Liu et al., 2004; Zivanovic et al., 2004). There are 
several proposed mechanisms of the antimicrobial actions of chitosan. The first proposed 
antibacterial mechanism of chitosan is due to electrostatic interactions between the chitosan 
amine group and the negatively charged lipopolysaccharides and proteins of the outer cell 
causing distortion of the cellular membrane and leakage of intracellular material (Coma et al., 
2003; Dutta et al., 2009; Helander et al., 2001; Kong et al., 2008; Liu et al., 2004). In a study, E. 
coli and S. Typhimurium were treated with 0.025% of 85% DDA chitosan, which modified the 
outer membrane of the cell and formed a layer around E. coli (Helander et al. 2001). Researchers 
suggested that chitosan affects Gram-positive and Gram-negative cells differently. They 
proposed that higher molecular weight chitosan forms a polymer membrane in order to prevent 
nutrients from entering and leaving the cell of Gram-positive organisms, whereas lower 
molecular weight chitosan enters the Gram negative cell to bind to electronegative substances, 
which results in flocculation in the cytoplasm as well as disruption of physiological processes 
(Zheng and Zhu, 2003). Chitosan is shown to inhibit mRNA as well as protein synthesis by 
penetrating the cell of the microorganism and binding with DNA (Sudarshan et al., 1992). 
Another proposed antibacterial mechanism of chitosan is the chelation of essential nutrients 
required for microbial growth (Dutta et al., 2009). A study has found that chitosan microspheres 
of 1456 kDa were chelating Mg2+ of the E. coli outer membrane causing destabilization of the 
cell (Kong et al., 2008).  
Studies have shown the interaction of chitosan with the cell plasma membrane causing 
leakage of intracellular material (El Ghaouth et al., 1992; Liu et al., 2007). Chitosan and chitosan 
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derivatives of less than 120 kDa (85% Degree of Deacetylation (DDA)) at 1% concentrations 
reduced the growth of Botrytis cinerea due to a permeability change in the plasma membrane 
(Badaway et al., 2004). Chitosan hydrochloride of 120 kDa caused disruption of the plasma 
membrane leading to permeable cells in Candida albicans, C. krusei, and C. glabrata (Seyfarth 
et al., 2008). Chitosan was found to be effective in either inducing natural plant resistant 
mechanisms or was able to control fungal growth through fungistatic properties in B. cinerea 
infection in strawberries (Reddy et al., 2000). Chitosan has been shown to cause leakage of 
amino acids as well as morphological changes due to the accumulation of chitosan in the cell 
wall of Rhizopus stolinfer and B. cinerea (El Ghaouth et al., 1992). Chitosan has been shown to 
be involved in the chelation of Ca2+, Zn2+, and other essential minerals required for fungal 
growth (Cuero et al., 1991; Roller and covill, 1999). In Fusarium solani, chitosan has been 
shown to interfere with conformation or physical properties of DNA (Hadwiger et al., 1981). At 
pre-harvest, chitosan was shown to exhibit indirect antiviral activity by penetrating the plant cell 
to induce resistance (Kulikov et al., 2006). At post-harvest chitosan was shown to cause 
structural damage to the virus (Kochkina and Chirkov., 2000a) and electron microscopy revealed 
that chitosan caused loss in viral tail fibers with receptors and viral sheath contraction exposing 
DNA of phage T2 and 1-97A (Kochkina et al., 2000c). Chitosan is hypothesized to interact with 
the negative charge of the viral capsids (Kochkina et al., 2000b; Su et al., 2009). Chitosan has 
been reported to inhibit the lytic infection of bacteriophage T2 and T7 after adsorption into the 
host by possibly attaching to the viral particles in the cell (Kochkina et al. 1995). Chitosan 
inhibits viral replication of phages T2 and T7 (Chirkov, 2002; Kochkina and Chirkov, 2000a). 
Chitosan was found to be efficient at inhibiting phage replication of bacteriophage 1-97A in B. 
thuringiensis, which may be due to the interruption of the intracellular reproduction of the 
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phages (Kochkina and Chirkov, 2000a). The effectiveness and mechanisms of action of chitosan 
against foodborne viruses needs to be investigated. 
Recently, chitosan was shown to be effective against human noroviral surrogates, where 
water-soluble chitosan (53 kDa) at 1.4% decreased FCV-F9 titers by ~2.83 log PFU/ml at 37ºC 
after 3 h with decreasing effects at lower concentrations (Su et al., 2009).  These researchers 
showed that bacteriophage MS2 was reduced by ~1.18 to 1.41 log PFU/ml irrespective of the 
chitosan (at 53 kDa) concentration used, without any reported effect against MNV-1. Chitosan 
oligosaccharide showed similar viral reduction trends but to a lesser extent compared to that of 
water-soluble chitosan at 53 kDa (Su et al., 2009).  
The effectiveness of different molecular weight chitosans (53, 222, 307, 421, ~1150 kDa) 
at 0.7% against feline calicivirus, FCV-F9, murine norovirus, MNV-1, bacteriophages MS2 and 
phiX174 for 3 h at 37 ºC was determined. Water-soluble chitosan of 53 kDa reduced phiX174, 
MS2, FCV-F9 and MNV-1 titers by 0.59, 2.44, 3.36, and 0.34 log10 PFU/ml respectively. 
Molecular weight increase of chitosan corresponded with an increase in antiviral effect for MS2, 
but did not play a role for the other three tested viral surrogates. Overall, chitosan treatments 
showed the greatest reduction for FCV-F9, and MS2 followed by phiX174, and with no 
significant effect on MNV-1(Davis et al., 2012). 
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Based on literature, the working hypotheses were as follows: 
1. Increasing the concentration of chitosan could result in increased inactivation of virus due 
to the interaction of more available positive charges of chitosan with negatively charged 
components of the virus capsid. 
2. Increasing the temperature and incubation time could result in improved antiviral activity 
of chitosan. 
3. Potentially higher molecular weight of chitosan could result in greater damage to the viral 
structure than lower molecular weight chitosan resulting in greater viral reduction. 
4. The viral surrogates used would mimic the behavior of human noroviruses in the 
presence of chitosan. 
The specific research objectives were: 
1) To determine the in vitro time and temperature dependence effects of three different 
molecular weight (53, 421 and ~ 1150 kDa) chitosans against human norovirus 
surrogates, FCV-F9 and MNV-1 over 2 h at 18oC and 37oC using two concentrations 
(0.7% and 0.35%). 
2) To understand the potential antiviral mechanism of chitosan by 
a) Determining any structural changes to the virus caused by chitosan using 
Transmission Electron Microscopy.  
b) Determining if chitosan prevents viral host cell entry or prevents replication, 
using blocking experiments. 
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Abstract 
Chitosan is known to have a broad spectrum of antimicrobial activity. Human noroviruses are the 
leading cause of non-bacterial gastroenteritis, yet information on the efficacy of chitosan against 
foodborne viruses including human noroviruses is very limited. The objectives of this research 
were to determine the in vitro time and temperature-dependent effects of chitosan with different 
molecular weights (53, 421 and ~ 1150 kDa) using two concentrations (0.7% and 0.35%) at two 
temperatures (37oC and 18oC) over 2 h against the human noroviral surrogates, feline calicivirus 
(FCV-F9), and murine norovirus (MNV-1). Each treatment run twice in duplicate was 
neutralized in cell-culture media containing 10% fetal bovine serum before determining viral 
recovery by plaque assays for comparison to untreated virus controls. Chitosan at 53 kDa with 
0.35% decreased FCV-F9 by ~1.0 log PFU/ml after 2 h at 37oC, whereas 0.7% caused a 
reduction of ~3.0 log PFU/ml after 2 h at 37oC and ~1.0 log PFU/ml after 1 and 2 h at 18oC. 
Chitosan at 421 kDa and 0.7% and 0.35% at 37oC for 2 h decreased FCV-F9 titers by ~2.0 and 
~1.0 log PFU/ml, respectively. Chitosans at 421 and ~ 1150 kDa at both concentrations 
decreased FCV-F9 titers by ~1.0 log PFU/ml after 2 h at 18oC.  At 37oC, the ~1150 kDa chitosan 
at 0.7% and 0.35% decreased FCV-F9 titers by ~2.0 and ~1.0 log PFU/ml, respectively after 2 h. 
In general, these results showed that higher chitosan concentration, higher temperature, and 
longer incubation period have a greater effect, with 53 kDa chitosan showing the greatest effect 
on FCV-F9 and had no observable effects on MNV-1. 
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Introduction 
Foodborne viruses are recognized as the major causes of foodborne illness responsible for 
5.5 of the 9.4 million foodborne cases (59%), 27% of the 55,961 hospitalizations, and 12% of the 
1,351 deaths related to food contamination (Scallan et al., 2011; Mead et al., 1999; Patel et al., 
2008). Human noroviruses of the Caliciviridae family have single-stranded positive-sense RNA 
genomes of about ~7.5kb in size (Jiang et al.,, 1990; Perry and Wobus, 2010). They are non- 
enveloped, isocahedral in shape, about 27-38 nm in size, and only need about 10-100 particles to 
cause infection (Bok et al., 2009; Cheesbrough et al., 2000; Hyde et al., 2009; Taube et al., 
2010). They are found to be sensitive to heat treatments and chlorine at concentrations >2mg/l, 
but have been found to be less susceptible to pH (Cliver et al., 2002; Koopmans et al. 2002). 
Viral transmission occurs from contaminated food and water, through the fecal-oral 
route, through person to food contact, person to person contact, person to environmental surface, 
contaminated vomit, or aerosolization (Greening, 2006b; Patel et al., 2009; Sair et al., 2002b). 
Handled and ready to eat foods which include fresh produce, juices, shellfish, salads, and boxed 
lunches that do not undergo further cooking conditions are considered at-risk foods (Grove et al., 
2006; Sair et al., 2002b) Currently cultivable surrogates, such as feline calicivirus (FCV-F9), 
murine norovirus (MNV-1), and bacteriophage MS2, are used in infectivity assays, since there is 
no laboratory host cell culture system for human norovirus propagation (Doultree et al., 1999; 
Duizer et al., 2004).  
FCV-F9 differs from the human noroviruses in being transmitted through the nasal, oral, 
or conjunctival routes causing a respiratory infection as well as in being more susceptible to low 
pH than enteric viruses (Cannon et al., 2006; Duizer et al., 2004; Perry et al., 2009; Radford et 
al., 2007). MNV-1, a member of the same Calicivirdae family and under the Norovirus genus, is 
considered a better surrogate system to study the biology and pathogenesis of the human 
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noroviruses, being more resistant to environmental conditions than FCV-F9 (Cannon et al., 2006; 
Green et al., 2001; Karst et al., 2003; Wobus et al., 2006).  Novel methods to control their spread 
and prevent disease transmission, including natural alternates are needed. 
 Chitosan is a linear cationic polysaccharide and a deacetylated derivative of chitin which 
is the major structural biopolymer in crustacean shells, fungi, and insects (Roller, and Covill,  
1999; Shahidi et al., 1999). Chitosan is not generally recognized as safe (GRAS) in the United 
States, although chitosan is approved as a food additive in Japan and Korea (No et al., 2007). 
Chitosan has been sold as a dietary supplement and as an additive to dog food (Park et al., 2002) 
and accepted as a biopesticide in the United States (Docket No. EPA-HQOPP- 2007-0566-0019). 
Chitosan is used to form beads, films, fibers, and gels (Guibal 2004; Sankararamakrishnan et al., 
2006; Zivanovic et al. 2008), as a chelator,  in waste water management (Shahidi et al., 1999), 
and as wound dressings in medicine (Koide, 1998).  The use of chitosan in the food industry has 
been explored in various fields, as clarifying agent in juice, as an antimicrobial, as an 
antioxidant, as a packaging material, and as a thickening agent in beverages (Devlieghere et al., 
2004; Shahidi et al., 1999; Xie et al., 2001).       
The antibacterial properties of chitosan have been widely confirmed and investigated 
(Coma et al., 2003; Dutta et al., 2009; Kong et al., 2008; Liu et al., 2004; Zivanovic et al., 2004). 
At pre-harvest, chitosan has been shown to exhibit indirect antiviral activity by penetrating the 
plant cell to induce resistance (Kulikov et al., 2006). At post-harvest chitosan has been shown to 
cause viral structural damage (Kochkina and Chirkov, 2000a).  
Recently, chitosan has been shown to be effective against human noroviral surrogates. 
Chitosan effect was determined on human enteric viral surrogates, murine norovirus (MNV-1), 
feline calicivirus (FCV-F9), and MS2 (ssRNA) bacteriophage. Chitosan oligosaccharide lactate 
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with a molecular weight of  <5kDa and water-soluble chitosan with a molecular weight 53kDa at 
concentrations of 1.4%, 0.7%, and 0.35% were incubated at 37ºC for 3 h. At 0.7% the water-
soluble chitosan decreased FCV-F9 titer by ~2.83 log PFU/ml, with decreasing effects at lower 
concentrations and reduced MS2 at ~7 log PFU/ml by ~1.18 to 1.41- log PFU/ml irrespective of 
the concentration used. Chitosan treatments at the same concentrations had no effect on MNV-1 
at ~7 log PFU/ml. Chitosan oligosaccharide had similar trends but to a lesser extent compared to 
that of water-soluble chitosan against the viruses. Plaque reduction was observed for FCV-F9 
and MS2, but not for MNV-1, when ~5 log PFU/ml were used (Su et al., 2009). Water-soluble 
chitosan of 53 kDa was reported to reduce phiX174, MS2, FCV-F9 and MNV-1 titers by 0.59, 
2.44, 3.36, and 0.34 log PFU/ml respectively. Molecular weight increase of chitosan 
corresponded with an increase in antiviral effect for MS2, but did not play a role for the other 
three tested viral surrogates. Overall, chitosan treatments showed the greatest reduction for FCV-
F9, and MS2 followed by phiX174, and with no significant effect on MNV-1 (Davis et al., 
2012).The specific research objectives were a) To determine the in vitro time and temperature 
dependence effects of three different molecular weight (53, 421 and ~ 1150 kDa) chitosans 
against human norovirus surrogates, FCV-F9 and MNV-1 over 2 h at 18oC and 37oC using two 
concentrations (0.7% and 0.35%) and b) to understand the potential antiviral mechanism of 
chitosan by determining any structural changes to the virus caused by chitosan using 
Transmission Electron Microscopy and determining if chitosan prevents viral host cell entry or 
prevents replication, using blocking experiments. 
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Materials and Methods 
Viruses, hosts and cell lines. 
FCV-F9 and Crandell Reese Feline Kidney (CRFK) cells were purchased from ATCC 
(Manassas, VA) and murine norovirus, MNV-1, was provided as a gift by Dr. Skip Virgin 
(Washington Univ., St Louis, MO). RAW 264.7 cells (Murine Macrophage Leukemia cell line) 
were obtained from the University of Tennessee at Knoxville.  
Virus Propagation and Preparation. 
CRFK for FCV-F9 and Raw 264.7 for MNV-1 were incubated at 37°C with 5% CO2 in 
Dulbecco‘s modified Eagle‘s medium (DMEM-F12) with 1% penicillin-streptomycin and 10% 
heat-inactivated fetal bovine serum (FBS). CRFK cells were infected with FCV-F9 and RAW 
264.7 cells were infected with MNV-1, incubated at 37°C with 5% CO2 until > 90% lysis, 
around ~24 h for FCV-F9 and 4 to 6 days for MNV-1. The viruses were harvested by freeze-
thawing, once for FCV-F9 and three times for MNV-1 after lysis, and centrifuged at 5,000 x g 
for 10 min. Supernatants were filtered through a 0.22 μm membrane filter and 1 ml aliquots 
stored in vials and frozen at - 80°C until use. 
Chitosan preparation and application for viral inactivation. 
Preparation of 53 kDa chitosan.  
Chitosan with a molecular weight of 53 kDa was purchased from EZ Life Science Co. Ltd 
(Seoul, South Korea) as previously reported (Su et al., 2009). The chitosan was dissolved in 
sterile deionized distilled water at concentrations of 1.4% and 0.7% and stored as stock for use. 
Preparation of 421 and ~ 1150 kDa chitosans.  
421 kDa chitosan (30.3 % DA) from Primex (Iceland) and high molecular weight chitosan 
(estimated ~ 1150 kDa; 25% DA) from Aldrich (St. Louis, MO) were prepared at 1.4% (w/v) in 
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1% acetic acid and filtered through 0.22 μM filter. Since previous research (Davis et al., 2010) 
showed that acetic acid in the concentrations used in this experiment had no effect on the viruses 
tested, acid controls were not used. Thus, the data are treated as effect of molecular weight of 
chitosan and not as effect of solvent used. 
Chitosan Treatment. 
FCV-F9 at a titer of 7 log PFU/ml and MNV-1 at a titer of 6 log PFU/ml were incubated with 
equal volumes of each chitosan to obtain a final concentration of 0.7% and 0.35% and incubated 
at 37°C or 18oC for 2 h. Treatments after each time point were stopped and neutralized in 
DMEM-F12 media containing 10% heat-inactivated FBS, serially diluted with cell culture media 
containing fetal bovine serum (FBS), and plaque assayed as described below. Each treatment 
was carried out in duplicate and replicated twice. Untreated controls included incubation of each 
virus with phosphate buffered saline (1X PBS, HyClone, Logan, Utah) at the two temperatures, 
followed by serial dilutions and plaque assays to determine viral infectivity.  
Infectious Plaque Assays. 
FCV-F9 plaque assays were conducted using confluent CRFK cells in 6-well plates as described 
earlier (Su et al., 2009). Briefly, 0.5ml of the tenfold serial dilutions of untreated or chitosan 
treated samples in DMEM-F12 containing 2% FBS was inoculated into each well. Viruses were 
adsorbed for 2 h at 37oC and overlaid with 2 ml of DMEM-F12 containing 0.75% agarose, 2% 
FBS and 1% penicillin-streptomycin. Plates were incubated for 48 h and overlaid with a second 
overlay media containing 0.01% neutral red (Sigma). Plaques were counted after incubation at 
37oC for 20-24 h. 
For MNV-1, the plaque assay described by Wobus et al. (2004) and Su et al. (2009) was 
followed. Briefly, RAW 264.7 cells were seeded onto 6-well plates and incubated until ~90% 
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confluency and 0.5 ml of the ten-fold serial dilutions of chitosan treated or untreated viral 
samples were inoculated into each well after aspiration of media. Viruses were adsorbed for 2.5 
h at 37°C and then overlaid with 2 ml of DMEM-F12 containing 0.75% agarose, 10% FBS and 
1% penicillin-streptomycin and incubated for 72 h under 5% CO2. A second overlay media 
containing 0.02% neutral red (Sigma, St. Louis, MO) was used and plaques were counted after 
incubation at 37oC in a CO2 incubator for 3-5 h. 
Transmission Electron Microscopy (TEM) of chitosan treated FCV-F9 and MNV-1.  
TEM studies were carried out at the UT-Knoxville Advanced Microscopy and Imaging Center 
with the assistance of Dr. John Dunlap to determine the effect of 53 kDa chitosan on FCV-F9 
and MNV-1 titer reduction. Chitosan of 53 kDa was treated with FCV-F9 or MNV-1 including 
the untreated FCV-F9 in PBS (control), incubated at 37oC or 18oC for 2 h and 10 µl of each 
sample was applied to a freshly glow discharged, formvar (support film for TEM grids) and 
carbon coated copper grid. After 1 min, excess sample was removed and the remaining sample 
was stained with uranyl acetate for 1 min and allowed to dry. The stained viruses were examined 
in a Hitachi H800 operating at 75 keV. Images were recorded on Kodak 4489 film. 
Chitosan blocking and virus infection assay. 
The mechanism of action of chitosan (to determine viral adsorption/attachment prevention to 
host cells by chitosan) on the viral surrogates was determined by first blocking the confluent cell 
lines of RAW 264.7 or CRFK in 6-well plates with two concentrations (0.7% and 0.35%) of 421 
kDa chitosan, incubated at 37ºC or 18oC for 2 h, followed by infection of confluent cell lines 
with MNV-1 or FCV-F9 for 2 h in a CO2 incubator, and plaque assay was done as described 
above. Chitosan effect on viral replication was determined by first infecting the confluent cell 
lines in 6-well plates (RAW 264.7 or CRFK) with MNV-1 or FCV-F9, for 2 h in a CO2 
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incubator, followed by blocking of confluent cell lines with 421 kDa chitosan (0.7% and 0.35%) 
at 37ºC or 18oC for 2 h, and plaque assay was done as described above.  
Statistical Analysis. 
 Data from the two replicate treatments were analyzed using ANOVA and Tukey’s test on a 
completely random design (SAS, Cary, NC).  
Results and Discussion 
Plaque reduction by 53 kDa chitosan. The time dependence of 53 kDa chitosan against 
foodborne viral surrogates, MNV-1 and FCV-F9 in vitro showed that at both temperatures, 
increasing contact time increased the reduction of FCV-F9 titers (Figure 1), but showed no effect 
on MNV-1 (Table 1). Chitosan at 0.7% decreased FCV-F9 titers by 0.2, ~ 0.3, ~0.8, ~1.5, and ~3 
log PFU/ml at 37ºC after 5, 15, 30 min, 1 h, and 2 h, respectively, having almost negligible 
reduction within the first 15 min. Decreasing the concentration of chitosan to 0.35% resulted in 
lower FCV-F9 titer reductions of ~0.6 log PFU/ml after 2 h at 37oC with insignificant reductions 
at ≤1 h at 37oC (P>0.05) (Figure 1). These results show that 53 kDa chitosan had a dose 
dependent effect on FCV-F9 at 37oC. At 18oC, 53 kDa chitosan at 0.7% decreased FCV-F9 titers 
by ~0.5 and ~1 log PFU/ml after 1 and 2 h respectively, with insignificant reductions at ≤30 min 
at 18oC (P>0.05). Decreasing the concentration of chitosan to 0.35% showed decreased titer 
reductions for FCV-F9, where only ≤1 log PFU/ml at 18oC were obtained.  In the case of 53 kDa 
chitosan, higher temperature, higher concentration, and longer contact times had increased 
effects on FCV-F9 titer reductions. On the other hand, MNV-1 treated with 53 kDa chitosan at 
concentrations, time and temperatures studied, showed minimal to no reductions in viral titers. 
The number of MNV-1 plaques recovered was found to be similar to those of the untreated virus 
controls (Table 1).  
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Plaque reduction by 421 kDa chitosan.  
At both temperatures, 421 kDa chitosan with increased contact time caused the reduction of 
FCV-F9 titers (Figure 2), but had no effect on MNV-1 titers. Chitosan at 0.7% reduced FCV-F9 
by ~ 2 and 1 log PFU/ml at 37ºC and 18oC, respectively, after 2 h. Shorter incubation times of 5, 
15, 30 min, and 1 h at 0.7% resulted in FCV-F9 reductions of ~0.4, ~0.4, ~1, and ~1  log PFU/ml 
at both temperatures. Incubation of the virus with 0.35% 421 kDa chitosan for  5, 15, 30 min, 1 
h, and 2 h caused FCV-F9 reductions of 0.2, 0.2, ~ 1, ~ 1, and ~ 1 log PFU/ml, respectively at 
both  temperatures. Thus, for 421 kDa chitosan increasing the temperature or dose did not appear 
to play a significant role in FCV-F9 titer reduction. However, the effect was time dependent with 
increasing contact time showing increasing titer reduction at 0.7 % after 2 h at 37ºC. In contrast, 
MNV-1 treated with 421 kDa chitosan at both concentrations and temperatures showed minimal 
to no reductions in virus survival compared to untreated controls (Table 1). 
Plaque reduction by ~ 1150 kDa. 
At both temperatures, ~1150 kDa chitosan with increased contact time enhanced reduction of 
FCV-F9 titers (Figure 3), but with no significant effect on MNV-1 titers. The chitosan at 0.7% 
for 2h, showed FCV-F9 reductions of 2 and 1.0 log PFU/ml, respectively at 37ºC and 18oC. 
Incubation of the virus with 0.7% of  ~1150  kDa chitosan for  5, 15, 30 min, and 1 h showed 
FCV-F9 reductions of ~0.4, ~ 0.8, ~1,  and ~1  log PFU/ml, respectively at both temperatures. 
Incubation of the virus with 0.35% ~1150 chitosan for  5, 15, 30 min, 1 h, and 2 h showed FCV-
F9 titer reductions of ~0.3, ~ 0.6, ~1, ~1, and 1  log PFU/ml respectively, at both temperatures. 
Thus, for ~1150 kDa chitosan, increased chitosan concentration and temperature did not appear 
to play a significant role (p>0.05), but increasing contact time at 37ºC had an effect at 0.7% after 
2 h. Similar to 53 and 421kDa chitosans, MNV-1 treated with ~1150 kDa chitosan at both 
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concentrations and temperatures studied showed no reductions in viral titers and the number of 
MNV-1 plaques recovered were almost the same as untreated virus controls (Table 1).  
The results of this study are in agreement with the previous findings that MNV-1 is more 
resistant than FCV-F9 to inactivation treatments and to chitosan treatment. It has been reported 
that in the environment,  MNV-1 is more persistent and stable than FCV-F9 in waters at 25ºC 
(Bae et al., 2008), at basic and acidic pHs (Cannon et al., 2006), in the presence of  1-5% 
trisodium phosphate (TSP), 10% bleach and 1-2% glutaraldehyde (D'Souza and Su, 2010), and 
in the presence of a hand sanitizer which has a polyquaternium polymer and organic acid 
(Macinga et al.,2008). 
Bean plant resistance to bean mild mosaic virus increased as the molecular weight of 
chitosan increased from 3-50 kDa (Chirkov et al., 1998). In contrast, studies have shown that 
bean plant resistance to bean mild mosaic virus decreased as the molecular weight of chitosan 
increased from 1.2-40.4 kDa (Kulikov et al., 2006). Recently, Su et al. (2009) studied the direct 
effects of chitosan of different molecular weights on human noroviruses surrogates and 
demonstrated that 53 kDa chitosan reduced ~5 log PFU/ml viral titers of bacteriophage MS2 and 
FCV-F9 (1.70 and 4.21 log PFU/ml, respectively) more efficiently when compared to 5 kDa 
chitosan (0.98 and 1.41 log PFU/ml, respectively). Davis et al., (2012) studied the effectiveness 
of different molecular weight chitosans (53, 222, 307, 421, ~1150 kDa) against FCV-F9, MNV-
1, MS2 and phiX174. and found that water-soluble chitosan of 53 kDa reduced phiX174, MS2, 
FCV-F9 and MNV-1 titers by 0.59, 2.44, 3.36, and 0.34 log10 PFU/ml respectively. Molecular 
weight increase of chitosan corresponded with an increase in antiviral effect for MS2, but did not 
play a role for the other three tested viral surrogates.  
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In this study, the chitosans with the molecular weight of 421 and ~ 1150 kDa were found 
to be less effective in decreasing the infectivity of FCV-F9 than 53 kDa chitosan. Chitosans with 
421 and ~1150 kDa at 0.7% decreased FCV-F9 titers by ~2 and ~1 log PFU/ml after 2 h at 37oC 
and 18oC, respectively, while 0.35% for both chitosans decreased FCV-F9 by ~1 log PFU/ml 
after 2 h at both temperatures. 
In some earlier reports, the antiviral activity has been shown to be dependent on the 
concentration of chitosan.  When bean plants were sprayed with chitosan concentrations ranging 
0.00001-0.1% for 15 min before inoculation with alfalfa mosaic virus increasing inhibition of the 
virus with increasing concentration was found with complete inhibition at 0.01% (Prospieszny et 
al. 1991). An increase in infection inhibition from less than 50% to 100% against bacteriophage 
T2 and T7 was obtained when concentration of chitosan, chitosan acetate, and chitosan 
hydrochloride was increased from 0.00005 to 0.01% (Kochkina and Chirkov, 2000a).  
Recently our laboratory showed that an increase in concentration from 0.175, 0.35, to 
0.7% of 53 kDa caused a statistically significant increase in the reduction of initial titer of ~107 
(7- log) FCV-F9, which was 1.09, 2.09, 2.83 log PFU/ml, respectively, and 0.44, 0.99, 1.44 log 
PFU/ml, respectively, by 5 kDa chitosan (Su et al., 2009). A similar trend was shown by 53 kDa 
and < 5 kDa chitosan against 5-log PFU/ml FCV-F9. Chitosan of 53kDa at 0.175% was shown to 
cause a slightly higher reduction (0.32 log PFU/ml) of MNV-1 compared to 0.7% chitosan of 53 
kDa (0.04 log PFU/ml). The same trend was seen for 53 kDa and < 5 kDa chitosan as 
concentration decreased against ~7 log PFU/ml MS2 and MNV-1. An increase or decrease in 
concentration of chitosan did not affect some viruses (Su et al., 2009). In this study, at both 
temperatures, increasing contact time enhanced the reduction of FCV-F9 with regard to 53, 421 
and ~1150 kDa chitosans.  The 53 kDa chitosan at 0.7% decreased FCV-F9 titers by ~3 and ~1 
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log PFU/ml after 2 h at 37oC and 18oC, respectively while 0.35% resulted in decreases of ~0.6 
and 0.03 log PFU/ml after 2 h at 37oC and 18oC, respectively.  
Transmission Electron Microscopy of chitosan treated FCV-F9 and MNV-1.  
Chitosan of 53 kDa treated with FCV-F9 or MNV-1 including untreated FCV-F9 in PBS 
(control) for 2 h at 37oC and 18oC were examined by Transmission Electron Microscopy (TEM) 
(Figure 4 A and B).  TEM results with chitosan did not help us to obtain a clear evidence of 
structural damage to the viral capsids. Extensive work on the interaction of chitosan with these 
surrogates is needed to obtain insights into the mechanism of action.  
Chitosan action in blocking and virus infection assay.  
To obtain insights into the mechanism of action by chitosan on the tested viral surrogates, 
blocking experiments were carried out. Inhibition of viral adsorption / attachment to host cells by 
chitosan was studied by first blocking of confluent host cell lines with different concentrations 
(0.7% and 0.35%) of 421 kDa chitosan, at 37ºC and 18oC for 2 h, followed by virus infection for 
2 h. Inhibition of viral replication by chitosan was studied by infecting the confluent cell lines 
with each virus, followed by blocking of confluent cell lines with 421 kDa chitosan at both 
concentrations and temperatures for 2 h. Blocking the cell lines with chitosan or viral infection of 
cell lines with 421 kDa chitosan did not show any observable reduction in FCV-F9 or MNV-1 
titers. The results obtained show that the chitosan did not have any significant effect in blocking 
viral binding to the host cells or at the stage of viral replication. This leads us to deduce that 
chitosan may interact with the virus capsid, causing alterations or damage to the structure to 
prevent infection. Therefore, extensive work on the interaction of chitosan with these surrogates 
is needed to obtain insights into the mechanism of action. 
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Studies have shown that chitosan exhibited indirect antiviral activity by penetrating the 
plant cell to induce resistance (Kulikov et al., 2006). Chitosan has been shown to interact with 
the negative charge of the viral capsids (Kochkina et al., 2000c; Su et al., 2009), cause viral 
inactivation due to structural damage (Kochkina et al., 2000c), interferes with a step in the viral 
replication (Chirkov, 2002; Kochkina et al., 2000c) and inhibits infection by phage (Kochkina et 
al., 1995). FCV has pI of 4.9 (Su et al., 2010) with a negative charge at pH 6.0, which is the pH 
of the mixture of chitosan and viruses used in these studies. The pI information for MNV-1 is not 
yet available. This suggests that the charge effect of chitosan could play a significant role on the 
inactivation of norovirus (NoV) surrogates. Currently, there is limited literature on the effect of 
chitosan on foodborne viruses (Su et al., 2009; Davis et al., 2012).  
Future research should focus on the effect of chitosan against other human enteric viruses 
such as hepatitis A Virus or rotaviruses, or Tulane virus as a human norovirus surrogate to 
explore the antiviral activity of chitosan against foodborne viruses. Many researchers have 
evaluated the application of chitosan coatings as well as films for its antimicrobial properties and 
to extend product shelf-life in food products like bread, produce, and meat (No et al., 2007). 
Based on this, the direct application of chitosan films or coatings on produce commodities to 
control foodborne viruses should be evaluated in the future.  
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Conclusion 
Antiviral effect of chitosan is dependent on chitosan concentration, contact time, temperature, 
and target viruses.Chitosan with three molecular weights (53, 421 and ~ 1150 kDa) decreased 
FCV-F9 titres, with no observable effects on MNV-1. Chitosans with 53 kDa had a greatest effect 
on decreasing FCV-F9 titers.Chitosan of higher molecular weight and higher concentration with 
longer contact times on MNV-1 may be required to cause decrease in viral titers. 
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CHAPTER III 
Conclusions 
The tested chitosans with three molecular weights (53, 421 and ~ 1150 kDa) were shown 
to decrease the infectivity of FCV-F9 with no observable effects on MNV-1. The antiviral 
properties of chitosan depend on the type of virus. Overall, FCV-F9 was most susceptible than 
MNV-1. When FCV-F9 and MNV-1 were compared, chitosan did not show any significant 
effects in reducing titers of MNV-1. 
These results indicate that the effect of chitosan in reducing viral plaque infectivity is 
dependent on the temperature and time. In case of 53 kDa chitosan, at higher temperature of 
37ºC, 0.35% had increased effects after 2 h and 0.7 % had increased effect after 30 min whereas 
at 18 ºC, 0.7% had increased effect after 1 h on FCV-F9 titer reductions. For 421 kDa chitosan 
increasing the temperature and time did not appear to play a significant role in FCV-F9 titer 
reduction from 30 min to 2 h, but increasing contact time at 37ºC had an effect after 2 h at 0.7% 
concentration. For ~1150 kDa chitosan, increased temperature and time did not appear to play a 
significant role from 15 min to 2 h, but increasing contact time at 37ºC had an effect after 2 h at 
0.7% concentration. 
The inactivation of FCVF9 was not molecular weight dependent while MNV-1 was not 
affected by chitosan. Chitosan with three molecular weights (53, 421 and ~ 1150 kDa) decreased 
FCV-F9 titers. Overall, the chitosans with the molecular weight of 421 and ~ 1150 kDa were 
found to be less effective in decreasing the infectivity of FCV-F9 than 53 kDa chitosan.  
Chitosan concentration play significant role in the antiviral activity. The 53 kDa chitosan 
at 0.7% decreased FCV-F9 titers by ~3 and ~1 log PFU/ml after 2 h at 37oC and 18oC, 
respectively while 0.35% resulted in decreases of ~0.6 and ~0.03 log PFU/ml after 2 h at 37oC 
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and 18oC, respectively. Chitosans with 421 and ~1150 kDa at 0.7% decreased FCV-F9 titers by 
~2 and ~1 log PFU/ml after 2 h at 37oC and 18oC, respectively, while 0.35% for both chitosans 
decreased FCV-F9 by ~1 log PFU/ml after 2 h at both temperatures. For 421 and ~1150 kDa 
chitosan, increased chitosan concentration did not appear to play a significant role but increasing 
contact time at 37ºC had an effect after 2 h at 0.7% concentration. 
To obtain insights into the mechanism of action by chitosan on the tested viral surrogate, 
the mechanism of chitosan action was evaluated. TEM results with 53 kDa chitosan did not help 
us to obtain a clear evidence of structural damage to the viral capsids. Blocking the cell lines 
with chitosan or viral infection of cell lines with 421 kDa chitosan did not show any observable 
reduction in FCV-F9 or MNV-1 titers. The results obtained show that the chitosan did not have 
any significant effect in blocking viral binding to the host cells or at the stage of viral replication. 
This leads us to deduce that chitosan may interact with the virus capsid, causing alterations or 
damage to the structure to prevent infection. Therefore, extensive work on the interaction of 
chitosan with the tested surrogates is needed. 
Overall, these results indicate that the effect of chitosan in reducing viral plaque 
infectivity is dependent on the target viruses, the temperature, time of contact, and concentration 
of chitosan. The chitosans with three molecular weights (53, 421 and ~ 1150 kDa) were shown to 
decrease the infectivity of FCV-F9, having no observable effects on MNV-1.  The chitosans with 
the molecular weight of 421 and ~ 1150 kDa were found to be less effective in decreasing the 
infectivity of FCV-F9 than 53 kDa chitosan. Thus, 53 kDa chitosan has the most antiviral effect 
against FCV-F9 among the three tested chitosans. For MNV-1,  the chitosans with two 
concentrations (0.7% and 0.35%) and three molecular weights (MW 53, 421 and ~ 1150 kDa)  
did not have significant effects in plaque reduction and MNV-1 was quite resistant to treatment 
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using the concentrations, time, temperature and different molecular weights of chitosan studied. 
For MNV-1, higher molecular weight chitosan, higher concentrations and longer incubation 
times may be necessary to cause reduction in viral titers. 
Future research should focus on the effect of chitosan against other human enteric viruses 
such as hepatitis A Virus or rotaviruses, or Tulane virus as a human norovirus surrogate to 
explore the antiviral activity of chitosan against foodborne viruses. Also the direct application of 
chitosan films or coatings on produce commodities to control foodborne viruses should be 
evaluated. Chitosan has antiviral activity against only one of the tested HNoV surrogates. Thus, 
caution must be used in interpreting the data based solely on chitosan’s effects against FCV-F9 
for the use of chitosan as a natural antiviral agent to control foodborne viral infections. 
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Appendix 
Table 1: The effect of chitosans (53, 421 and ~1150 kDa) on the recovery of MNV-1 titers at 37oC and 
18oC over time up to 2 h from a starting titer of ~ 6 log PFU/ml.  
            
        
            
Temperature Concentration  Time 53 kDa  421 kDa  ~ 1150 kDa 
  0.35% 0     0.02 
    5 0.25  - 0.05   
    15 0.13 0.11   
    30 0.16 0.05   
    60 0.26 0.02 0 
18oC   120 0.71 - 0.13 0.09 
  0.70% 0     0.04 
    5 0.56 - 0.06   
    15 0.31 0.01   
    30 0.14 0.14   
    60 0.28 0.06 0.13 
    120 0.71 - 0.06 0.07 
  0.35%  0     0.02  
    5 0.19 - 0.03  
    15 0.26 - 0.01   
    30 0.38 - 0.20   
    60 0.14 0.05 0.05 
37ºC   120 0.38 - 0.13  0.06 
  0.70%  0     0.05 
    5 0.66 0.11   
    15 0.3 - 0.04   
    30 0.77 0.15   
    60 0.39 - 0.02 0.13 
    120 0.76 - 0.28 0.03 
 
 
 
Recovery of  MNV-1 titers ( PFU/ml)  
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Figure 1. Effect of 53 kDa chitosan at 0.7% and 0.35% on the reduction of FCV-F9 titers at 37oC 
and 18oC over time up to 2 h from a starting titer of ~ 7 log PFU/ml using infectivity plaque 
assays. Each experiment was run in duplicate and results from the treatments and controls were 
analyzed statistically. 
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Figure 2. Effect of 421 kDa chitosan at 0.7% and 0.35% on the reduction of FCV-F9 titers at 
37oC and 18oC over time up to 2 h from a starting titer of ~ 7 log PFU/ml using infectivity 
plaque assays. Each experiment was run in duplicate and results from the treatments and controls 
were analysed statistically.  
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Figure 3. The effect of ~1150 kDa chitosan 0.7% and 0.35% on the reduction of FCV-F9 titers at 
37oC and 18oC over time up to 2 h from a starting titer of ~ 7 log PFU/ml using infectivity 
plaque assays. Each experiment was run in duplicate and results from the treatments and controls 
were analysed statistically 
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`  
Figure 4A: TEM images of FCV-F9 stained with uranyl acetate after 2 h incubation with PBS at 
37°C (Control) (a), 0.7% 53kDa chitosan at 18oC (b and c), and 0.7% 53kDa chitosan at 37ºC 
(d). 
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Figure 4B: TEM images of MNV-1 stained with uranyl acetate after 2 h incubation with PBS at 
37°C (Control) (a), 0.7% 53kDa chitosan at 18oC (b), and 0.7% 53kDa chitosan at 37ºC 
 
 
 
 
 
 
 
 
 
 
61 
 
Vita 
Radha Ganapathy was born on November 8, in Tamil Nadu, India. She grew up in Tamil Nadu, 
India. She continued her education in the United States, at the University of Tennessee, 
Knoxville where she earned a Master of Science degree in Microbiology at the Department of 
Microbiology. She joined the department of Food Science and Technology at the University of 
Tennessee, Knoxville in January 2010. She conducted research under Dr. Doris H. D‘Souza’s 
supervision. She is currently a candidate for a Master of Science degree in food science and 
technology. 
 
 
 
 
 
 
 
 
 
 
 
 
